AdvisorShares Investments’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

AdvisorShares Investments’s Portfolio REUN Stock Details REUN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-271,329	Closed	-$307K	–	301
2023 Q2	$307K	Sell	271,329 -71,200	-21%	-$60.4K	0.09%	178
2023 Q1	$236K	Buy	342,529 +212,288	+163%	+$237K	0.07%	179
2022 Q4	$117K	Buy	130,241 +20,089	+18%	+$29.3K	0.03%	238
2022 Q3	$161K	Buy	110,152 +47,105	+75%	+$168K	0.04%	241
2022 Q2	$265K	Sell	63,047 -7,968	-11%	-$39.8K	0.07%	128
2022 Q1	$476K	Buy	71,015 +25,347	+56%	+$211K	0.08%	113
2021 Q4	$562K	Buy	45,668 +37,198	+439%	+$796K	0.07%	107
2021 Q3	$194K	Buy	+8,470	New	+$213K	0.03%	145

AdvisorShares Investments's REUN Position: Q3 2023 in Review

AdvisorShares Investments sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q3 2023, closing a stake of 271,329 shares — an estimated $307K sold.

AdvisorShares Investments first reported a position in REUN in Q3 2021 and held it in 8 quarters. The position peaked at $562K in Q4 2021. 0 funds tracked by Wall St. Rank hold REUN as of Q3 2023.

AdvisorShares Investments reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q3 2023 after selling out during the quarter.
AdvisorShares Investments sold 271,329 Reunion Neuroscience Inc. Common Shares shares in Q3 2023, an estimated $307K.
AdvisorShares Investments first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 8 quarters.
AdvisorShares Investments's Reunion Neuroscience Inc. Common Shares position peaked at $562K in Q4 2021.
0 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q3 2023.

Based on AdvisorShares Investments's 13F filing for Q3 2023, filed 6 Nov 2023.